Cover image of the article: Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases

Image Credit:Hepat Mon

Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases

Authors

Behrooz Ataei1, Mohammad Reza Yazdani1, Hamid Kalantari1, Majid Yaran1, Zary Nokhodian1, Abbas Ali Javadi1, Anahita Babak1, Peyman AdibiPeyman Adibi ORCID2,*
1Isfahan Infectious Diseases Research Center, Isfahan University of Medical Sciences, IR.Iran
2Isfahan Infectious Diseases Research Center, Isfahan University of Medical Sciences, adibi@med.mui.ac.ir, IR.Iran
*Corresponding Author: Isfahan Infectious Diseases Research Center, Isfahan University of Medical Sciences, adibi@med.mui.ac.ir, IR.Iran. Tel: +98-3117923060. Fax: +98-3116687898. Email: adibi@med.mui.ac.ir

Hepatitis Monthly:Vol. 11, issue 4; 269-272
Published online:Apr 30, 2011
Article type:Research Article
Received:Mar 04, 2010
Accepted:Dec 20, 2010
How to Cite:Ataei B, Yazdani M, Kalantari H, Yaran M, Nokhodian Z, et al. Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases. Hepat Mon. 2011;11(4):. doi:

Abstract

Background: Hepatitis D virus (HDV) is dependent on hepatitis B virus (HBV) infection. Acute infection with HDV can occur simultaneously with acute HBV infection or be superimposed onto a chronic HBV infection.
Objectives: This study aimed to identify cases of HDV and determine its prevalence in patients with chronic HBV infection for the first time study in Isfahan, central Iran.
Patients and Methods: In a cross-sectional study in 2009, 346 who had been diagnosed for at least 6 months with chronic HBV were enrolled consecutively. Anti-HDV was measured by ELISA in the serum of these patients.
Results: The study included 245 males (70.8%) and 101 (29.2%) females with a mean age of 39 ± 12.4 years. Anti-HDV was present in 8 (3.5%) HBe antibody-positive patients (p = 0.36) and in 2 (2.3%) HBe antigen-positive cases (p = 0.68). No association was found between hepatitis D and probable risk factors.
Conclusions: This study demonstrates that the prevalence of HDV infection is higher in patients who are positive for HBeAb compared those who are HBeAg-positive. Therefore, most HDV antibody-positive cases in Isfahan are HBV/HDV superinfections but not coinfections.
Keywords: Hepatitis B infection; Hepatitis D infection; Prevalence


  • Implication for health policy/practice/research/medical education:
    Chronic HDV aggregates chronic hepatitis B infection in the patients. This original paper about super and co-infection of HDV is recommended for medical practitioners and specialists in the field of infection diseases and hepatologists as well as health policy makers.
  • Please cite this paper as:
    Ataei B, Yazdani MR, Kalantari H, Yaran M, Nokhodian Z, Javadi AA, et al. Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases. Hepat Mon. 2011;11(4):269-272.

© 2011 Kowsar M.P.Co. All rights reserved.


Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Dec
2009
Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran

Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran

Seyed Hashemi,
Fariba Jalali,
Eskandar Hajiani

Hashemi S, Jalali F, Hajiani E. Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran. Hepat Mon. 2009;9(4):. doi:

31
Dec
2011
A review on epidemiology, diagnosis and treatment of hepatitis D virus infection

A review on epidemiology, diagnosis and treatment of hepatitis D virus infection

Eskandar Hajiani,
Seyed Mohammad Alavi

Hajiani E, Alavi SM. A review on epidemiology, diagnosis and treatment of hepatitis D virus infection. Jundishapur J Microbiol. 2011;4(Suppl):. doi:

25
Aug
2013
Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012

Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012

Masood Ziaee,
Ghodsieh Azarkar

Ziaee M, Azarkar G. Prevalence of Hepatitis D Virus Infection Among Patients With Chronic Hepatitis B Attending Birjand Hepatitis Clinic (East of Iran) in 2012. Hepat Mon. 2013;13(8):e11168. doi: https://doi.org/10.5812/hepatmon.11168

6
May
2017
Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014

Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014

Gholamreza Sharifzadeh,
Mohammad Hasan Namaei,
Azadeh Ebrahimzadeh,
Zohreh Azarkar,
Mohammad Fereidouni,
Bita Bijari
,et al.

Sharifzadeh G, Namaei MH, Ebrahimzadeh A, Azarkar Z, Fereidouni M, et al. Prevalence of Hepatitis D Virus Infection and Associated Factors Among HBsAg-Positive Patients in Birjand, Iran, 2012 - 2014. Hepat Mon. 2017;17(5):e42866. doi: https://doi.org/10.5812/hepatmon.42866

31
Dec
2008
Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004

Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004

Seyed Alireza Taghavi,
Shabnam Sedighi,
Davood Mehrabani,
Farnaz Khademolhoesseini

Taghavi S, Sedighi S, Mehrabani D, Khademolhoesseini F. Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme Levels and Histopathology- an Epidemiological Study in Shiraz, Southern Iran, 2003-2004. Hepat Mon. 2008;8(4):. doi:

More by these authors

Behrooz AtaeiPubMedScholar
Mohammad YazdaniPubMedScholar
Hamid KalantariPubMedScholar
Majid YaranPubMedScholar
Zary NokhodianPubMedScholar
Abbas JavadiPubMedScholar
Anahita BabakPubMedScholar
Peyman AdibiPubMedScholar
Share
Cited by
Metrics